Phytosterols, Cholesterol Control, and Cardiovascular Disease
Autor: | Daniela Martini, Francesco Visioli, Andrea Poli, Franca Marangoni, Gerardo Medea, Alberto Corsini, Enzo Manzato, Walter Marrocco |
---|---|
Rok vydání: | 2021 |
Předmět: |
medicine.medical_specialty
Control (management) phytosterols Context (language use) Review Disease plant sterols supplements chemistry.chemical_compound Willingness to pay Functional Food cardiovascular disease medicine Humans media_common.cataloged_instance TX341-641 European union functional foods media_common Nutrition and Dietetics medicine.diagnostic_test Nutrition. Foods and food supply Cholesterol business.industry cholesterol chemistry Cardiovascular Diseases Family medicine Dietary Supplements Lipid profile business Plant sterols Food Science |
Zdroj: | Nutrients, Vol 13, Iss 2810, p 2810 (2021) Nutrients |
ISSN: | 2072-6643 |
DOI: | 10.3390/nu13082810 |
Popis: | The use of phytosterols (or plant sterols) for the control of plasma cholesterol concentrations has recently gained traction because their efficacy is acknowledged by scientific authorities and leading guidelines. Phytosterols, marketed as supplements or functional foods, are formally classified as food in the European Union, are freely available for purchase, and are frequently used without any health professional advice; therefore, they are often self-prescribed, either inappropriately or in situations in which no significant advantage can be obtained. For this reason, a panel of experts with diverse medical and scientific backgrounds was convened by NFI—Nutrition Foundation of Italy—to critically evaluate and summarize the literature available on the topic, with the goal of providing medical doctors and all health professionals useful information to actively govern the use of phytosterols in the context of plasma cholesterol control. Some practical indications to help professionals identify subjects who will most likely benefit from the use of these products, optimizing the therapeutic outcomes, are also provided. The panel concluded that the use of phytosterols as supplements or functional foods to control Low Density Lipoprotein (LDL) cholesterol levels should be preceded by the assessment of some relevant individual characteristics: cardiovascular risk, lipid profile, correct understanding of how to use these products, and willingness to pay for the treatment. |
Databáze: | OpenAIRE |
Externí odkaz: |